Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| (9 intermediate revisions not shown.) | |||
| Line 9: | Line 9: | ||
**Anemia | **Anemia | ||
***[[Erythropoietin]] | ***[[Erythropoietin]] | ||
| + | |||
| + | **Antifungal | ||
| + | ***[[Noxafil]] | ||
| + | |||
| + | **Antimalarial | ||
| + | ***[[Malarial Dihydrofolate Reductase as Drug Target]] | ||
| + | |||
| + | **Anti-parasitic | ||
| + | ***[[Ivermectin|Drug: Ivermectin; Target: Glutamate-gated chloride channels]] | ||
**Asthma and other Pulmonary Disease States | **Asthma and other Pulmonary Disease States | ||
| Line 20: | Line 29: | ||
**Autoimmune Diseases | **Autoimmune Diseases | ||
***[[Prolyl Endopeptidase]] | ***[[Prolyl Endopeptidase]] | ||
| - | ***[[Tumor | + | ***[[Tumor necrosis factor receptor]] |
***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
**Bacterial Infections | **Bacterial Infections | ||
*** See: [[Bacterial Infections]] | *** See: [[Bacterial Infections]] | ||
| + | ***[[Treatment of Tuberculosis]] | ||
**Blood Clots, Haemophilia, & Thrombic Events | **Blood Clots, Haemophilia, & Thrombic Events | ||
| Line 46: | Line 56: | ||
**Digestive Diseases | **Digestive Diseases | ||
| - | *** | + | ***Proton Pump |
| + | ****[[Esomeprazole and H+/K+ - ATPase Interaction]] | ||
**Erectile Dysfunction | **Erectile Dysfunction | ||
| Line 60: | Line 71: | ||
*** See: [[Metabolic Disorders]] | *** See: [[Metabolic Disorders]] | ||
| - | **Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | + | **Schizophrenia, Bipolar Depression, Depression, Insomnia, and Anxiety Disorders |
***[[Dopamine receptor]] | ***[[Dopamine receptor]] | ||
***[[Adrenergic receptor]] | ***[[Adrenergic receptor]] | ||
***[[Histamine H1 receptor]] | ***[[Histamine H1 receptor]] | ||
***[[Opioid receptor]] | ***[[Opioid receptor]] | ||
| + | ***[[5-hydroxytryptamine receptor]] | ||
**Viral Infection | **Viral Infection | ||
| Line 74: | Line 86: | ||
*** [[Herpes Simplex Virus Thymidine Kinase]] | *** [[Herpes Simplex Virus Thymidine Kinase]] | ||
*** [[NS5B|RNA Dependent RNA Polymerase from Hepatitis C Virus]] | *** [[NS5B|RNA Dependent RNA Polymerase from Hepatitis C Virus]] | ||
| + | *** Poliovirus | ||
| + | ****[[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | ||
| + | *** [[Interferon]] | ||
}} | }} | ||
See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | ||
Current revision
The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.
See Pharmaceutical Drugs for descriptions and analysis of well known drugs
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
